Live feed07:00:00·108dPRReleasevia QuantisnowBioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home SettingByQuantisnow·Wall Street's wire, on your screen.BTAI· BioXcel Therapeutics Inc.Health Care
